XPAR
NK
Market cap2.02bUSD
Jul 10, Last price
21.14EUR
1D
0.96%
1Q
-1.95%
Jan 2017
-70.67%
IPO
-27.80%
Name
Imerys SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Imerys S.A., established in 1880 and based in Paris, France, is a global provider of specialized mineral-based solutions for a diverse range of industries. The company operates through two core segments: Performance Minerals and High Temperature Solutions. In the Performance Minerals division, Imerys offers additives for various applications, including decorative and protective paints, rubber products (such as tires, medical rubber, and cables), and adhesive and sealant formulations. It also supplies crucial minerals for both technical and traditional ceramics like wall and floor tiles, sanitaryware, and large slabs. Furthermore, this segment provides components for high-purity silicon metal, which is integral to aluminum alloys, electronics, and solar panels, as well as materials for construction uses like insulation ceiling tiles. Functional additives for plastics and thermosets are also provided for the automotive, construction, packaging, and hygiene industries. Additional offerings include fillers and coatings for graphic paper and packaging, filtration agents for liquids and blood plasma, and graphite and carbon-based solutions vital for lithium-ion and alkaline batteries, fuel cells, and polymers. The High Temperature Solutions segment focuses on refractory minerals and solutions specifically designed for industrial processes that demand extreme heat. This segment also delivers bentonite for foundry molds, alumina and zirconia for abrasive applications, and high-performance binders used in construction for dry mix mortars and floor screeds. Imerys serves a broad spectrum of industries globally, including construction, paper and board, mobile energy, steelmaking, agriculture, food, automotive, and cosmetics. The company is a subsidiary of Belgian Securities BV.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||